Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 23 Feb 2018 |
2 | Reply to Exam Report (MIS-R) | 11 Apr 2018 |
3 | Authorization Letter | 24 Dec 2019 |
4 | Journal Copy | 19 Sep 2020 |
5 | Certificate | 15 Nov 2020 |
6 | TM-O(NOTICE OF OPPOSITION) | 23 Nov 2020 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 10 Nov 2022 |
1 | Hearing Notice (Show Cause) | 8926401 | 4407421 | 16 Sep 2019 |
2 | Hearing notice (Adjourned) | 9351343 | 4618290 | 04 Dec 2019 |
3 | Tribunal Accepted Notice for : 3762611 | 10086362 | 4908340 | 20 Jun 2020 |
4 | Opposition Notice | 10837271 | 5050461 | 17 Dec 2020 |
5 | Opposition Counter Statement | 11182124 | 5135326 | 01 Mar 2021 |
6 | Generate Report | 14127102 | 5730897 | 23 Sep 2022 |
7 | General Order | 14361985 | 5778144 | 18 Nov 2022 |
The application for Tylomax was made on 23 February 2018.
The trademark applicant for Tylomax is INTAS PHARMACEUTICALS.
Tylomax is applied in class(es) 5.
Application for Tylomax is on Accepted & Advertised stage.
Application Id allotted to Tylomax is 3762611.
Trademark agent or attorney for the application is Y. J. Trivedi & Co.
Tylomax filed with the Intellectual property office as a WORD.